Panoncial, Anna Rhodora G.
HRN: 26-46-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2024
CO-AMOXICLAV 625MG (TAB)
12/30/2024
01/05/2025
PO
500 Mg
BID
PROM X 14 Hrs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes